Market Overview:
The global Mosapride market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type, application and region. By type, the market is segmented into tablet, capsule and others. By application, the market is segmented into gastritis, dyspepsia and others. The North American region dominates the global Mosapride market followed by Europe and Asia Pacific. The growth in this region can be attributed to factors such as rising prevalence of gastrointestinal disorders coupled with increasing awareness about available treatment options among patients.
Product Definition:
Mosapride is a drug used to treat gastric problems such as heartburn, acid reflux and GERD. It works by increasing the amount of stomach acid that is expelled from the stomach, which helps to reduce symptoms. Mosapride is important because it can provide relief from common gastric problems without the need for prescription medications.
Tablet:
Tablet is a form of oral solid dosage drug delivery which is made up of inert materials like plastics and glass. It’s major function in the pharmaceutical industry is to act as an external support for the active ingredients, this allows rapid absorption with minimum side effects. The most common types of tablets are film-coated, effervescent, and disintegrating tablets. Tablets are also available in multiple shapes such as chevrons, diamonds, rectangles etc.
Capsule:
Capsule is a small package containing active ingredients. It is used to protect drugs and other substances from light, moisture, and air. In addition, it also helps in smooth delivery of the contents by maintaining the integrity of dosage form.
The U.S Food and Drug Administration (FDA) has approved capsule as an oral solid dose drug product for human consumption; which contains Mosapride (aspirin free base).
Application Insights:
The gastritis segment dominated the market in 2017. This is attributed to the growing prevalence of lifestyle disorders, such as obesity and lack of physical exercise, which has resulted in an increased number of patients suffering from acid reflux disease (ARD). Mosapride acts as a proton pump inhibitor, which blocks gastric acid production thereby reducing stomach acidity. As a result, it reduces the damage caused by excess acids in the stomach and thus improves digestion. It also reduces heartburn symptoms including nausea and dizziness caused due to excessive gas formation within abdomen.
Dyspepsia is another major application segment owing to rising incidences of indigestion and heartburn among adults worldwide.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through 2030, with the U.S. being the major revenue contributor and Canada being a strong second place finisher. North America has been witnessing increasing cases of lifestyle-related diseases such as diabetes and obesity, which are further fueling demand for mosapride based products in this region.
Asia Pacific is anticipated to be one of the fastest growing regions over the forecast period owing to rising disposable income levels, improving healthcare infrastructure coupled with an increase in awareness about new generation medicines among patients & physicians especially in developing countries like India & China will drive growth during this period Mosapride capsule was approved by FDA (Food.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 5.0% from 2016 to 2020, reaching nearly 1.5 billion by 2020. This growing population is susceptible to various gastrointestinal problems such as constipation, diarrhea, and gastric reflux disease (GERD), which are the key indications for mosapride therapy.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as diabetes and obesity is increasing globally, which in turn is leading to an increase in the number of patients with gastrointestinal problems. This will create a high demand for mosapride products in the coming years.
- Technological advancements: There has been a significant advancement in drug delivery technologies over the past few years, which has led to the development of novel oral formulations of mosapride that offer improved patient compliance and convenience compared with traditional tablets or capsules dosage forms.. These new formulations are likely to boost market growth during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Mosapride Market Research Report
By Type
Tablet, Capsule, Others
By Application
Gastritis, Dyspepsia, Others
By Companies
Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO, SAWAI PHARMACEUTICAL CO., LTD.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Mosapride Market Report Segments:
The global Mosapride market is segmented on the basis of:
Types
Tablet, Capsule, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gastritis, Dyspepsia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sumitomo Dainippon Pharma
- Konghong Pharmaceutical
- Dainippon Pharmaceutical Co., Ltd.
- Nihon Generic
- NIPPON CHEMIPHAR CO., LTD.
- Lunan Pharmaceutical Group
- HAOSON PHARMA
- DAIICHI SANKYO
- SAWAI PHARMACEUTICAL CO., LTD.
Highlights of The Mosapride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Others
- By Application:
- Gastritis
- Dyspepsia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mosapride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mosapride is a medication used to treat nausea and vomiting. It is taken by mouth. Mosapride works by blocking the action of certain chemicals in the brain that cause nausea and vomiting.
Some of the key players operating in the mosapride market are Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO, SAWAI PHARMACEUTICAL CO., LTD..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mosapride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mosapride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mosapride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mosapride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mosapride Market Size & Forecast, 2018-2028
4.5.1 Mosapride Market Size and Y-o-Y Growth
4.5.2 Mosapride Market Absolute $ Opportunity
Chapter 5 Global Mosapride Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mosapride Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mosapride Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mosapride Market Size Forecast by Applications
6.2.1 Gastritis
6.2.2 Dyspepsia
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mosapride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mosapride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mosapride Analysis and Forecast
9.1 Introduction
9.2 North America Mosapride Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mosapride Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mosapride Market Size Forecast by Applications
9.10.1 Gastritis
9.10.2 Dyspepsia
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mosapride Analysis and Forecast
10.1 Introduction
10.2 Europe Mosapride Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mosapride Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mosapride Market Size Forecast by Applications
10.10.1 Gastritis
10.10.2 Dyspepsia
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mosapride Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mosapride Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mosapride Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mosapride Market Size Forecast by Applications
11.10.1 Gastritis
11.10.2 Dyspepsia
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mosapride Analysis and Forecast
12.1 Introduction
12.2 Latin America Mosapride Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mosapride Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mosapride Market Size Forecast by Applications
12.10.1 Gastritis
12.10.2 Dyspepsia
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mosapride Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mosapride Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mosapride Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mosapride Market Size Forecast by Applications
13.10.1 Gastritis
13.10.2 Dyspepsia
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mosapride Market: Competitive Dashboard
14.2 Global Mosapride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sumitomo Dainippon Pharma
14.3.2 Konghong Pharmaceutical
14.3.3 Dainippon Pharmaceutical Co., Ltd.
14.3.4 Nihon Generic
14.3.5 NIPPON CHEMIPHAR CO., LTD.
14.3.6 Lunan Pharmaceutical Group
14.3.7 HAOSON PHARMA
14.3.8 DAIICHI SANKYO
14.3.9 SAWAI PHARMACEUTICAL CO., LTD.
